PT-141 10 mg Melanocortin Research Peptide Vial

Read the PT-141 Research Guide. Review the research context and evidence limitations.

PT-141 (10 mg Vial) is supplied for controlled laboratory evaluation of PT-141 within Research Compounds studies.

• Research material: PT-141
• Listed strength and format: 10 mg Vial
• Research category: Research Compounds

PT-141 melanocortin research context

PT-141, also called bremelanotide, is an alpha-melanocyte-stimulating hormone analogue investigated in melanocortin signaling research. A 2004 primary study in female rats examined distinct behavioral endpoints after PT-141 exposure. The investigators reported selective changes in solicitation behavior without generalized motor activation. These animal-model findings describe a particular experiment, not a promised effect of this vial or evidence that the material is suitable for human use.

What to verify before ordering

The product lists 10 mg total material in a 3 mL vial. The container size does not specify solution concentration. For analytical or receptor-model work, request the current PT-141 lot documentation from SRP and review identity, measured peptide content and the analytical method. Literature references provide research context; batch-specific documentation addresses the supplied material.

For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.